Feature | July 11, 2014

ASTRO, AAPM Launch Radiation Oncology Incident Learning System

New patient safety initiative to educate and facilitate safer and higher quality radiation oncology care

ASTRO, AAPM Launch Radiation Oncology Incident Learning System

July 11, 2014 — The American Society for Radiation Oncology (ASTRO) and the American Association of Physicists in Medicine (AAPM) announced the launch of RO-ILS, or Radiation Oncology Incident Learning System, a new, national patient safety initiative to facilitate safer and higher quality radiation oncology care.

Announced at a congressional briefing in B-339 of the Rayburn House Office Building on Capitol Hill, and co-hosted by U.S. Reps. Frank Pallone and Ed Whitfield, ASTRO chair Colleen A.F. Lawton, M.D., FASTRO and John E. Bayouth, Ph.D., president of AAPM, unveiled the details of RO-ILS. Comments and perspective were also provided by Jeffrey Brady, M.D., MPH, director of the Center for Quality Improvement and Patient Safety at the Agency for Healthcare Research and Quality (AHRQ).

RO-ILS is an online portal that will allow radiation oncology centers to provide non-patient-specific data about the radiation therapy near-misses and safety incidents that have occurred at their facility in a secure, non-punitive environment. RO-ILS is the only medical specialty society-sponsored radiation oncology incident learning system within a federally recognized patient safety organization (PSO), Clarity PSO.

Data collected in RO-ILS will educate the radiation oncology community about how to improve safety and patient care. The platform will provide centers with the ability to track and analyze their data through a secure online interface. There are no fees for radiation therapy centers to participate in RO-ILS. RO-ILS can be used as a stand-alone incident learning system or as a complement to an institution’s existing system. A panel of experts chosen by ASTRO and AAPM, called the Radiation Oncology Healthcare Advisory Council (RO-HAC), will work with Clarity PSO, the independent PSO contracted to develop and to administer RO-ILS, to analyze the aggregate data and to inform radiation oncology safety procedures and processes, best practices, practice guidelines and/or recommendations.

“We are excited to partner with AAPM on the launch of RO-ILS, a centerpiece of ASTRO’s Target Safely initiative that demonstrates our commitment to safe and high-quality radiation oncology treatment,” said Lawton, chair of ASTRO’s board of directors. “The complex and highly specialized radiation care we deliver to cure cancers and to treat more than one million patients each year requires that we be continually vigilant to ensure the safety of our patients and our radiation oncology care team. We are grateful that Congress, through the Patient Safety and Quality Improvement Act of 2005, provides us with the necessary protections to use RO-ILS to gather invaluable patient safety information as we strive to provide the safest and highest quality radiation treatments. One error is too many, and learning from near-misses is crucial to averting errors.”

“We take great pride in our integral role in the radiation oncology treatment process, and we are pleased to have developed RO-ILS with our ASTRO partners to promote the safe delivery of radiation therapy treatments,” said Bayouth, president of AAPM. “RO-ILS is an exceptional endeavor that will provide enormous returns for our collective knowledge. The entire radiation oncology care team is devoted to the utmost accuracy and safety for the complex radiation therapy process. RO-ILS will support our achievement of these critical goals.”

For more information: www.pso.ahrq.gov, www.astro.org/roils

Related Content

California Protons Cancer Therapy Center Begins Breast Cancer Study Enrollment
News | Proton Therapy | April 25, 2019
California Protons Cancer Therapy Center announced two major efforts representing significant steps forward in breast...
Philips Unveils IntelliSpace Radiation Oncology at ESTRO 2019
News | Oncology Information Management Systems (OIMS) | April 25, 2019
Philips announced IntelliSpace Radiation Oncology, an intelligent patient management solution to manage complexity,...
Accuray Launches Synchrony Motion Tracking and Correction Technology for Radixact System
Technology | Image Guided Radiation Therapy (IGRT) | April 24, 2019
Accuray announced the launch of its Synchrony motion tracking and correction technology to be used with the Radixact...
New Study Redefines Therapeutic Dose Guidelines for Non-Small Cell Lung Cancer
News | Lung Cancer | April 23, 2019
Non-small cell lung cancer is a common cancer for both men and women. Many people who are diagnosed with this type of...
Comparison of state Medicaid fees for radiation oncology services for breast cancer and nonradiation oncology services per the Kaiser Family Foundation Index

Fig. 1: Comparison of state Medicaid fees for radiation oncology services for breast cancer and nonradiation oncology services per the Kaiser Family Foundation Index. (Agarwal et al, Red Journal, 2019) Credit: Elsevier

News | Radiation Therapy | April 22, 2019
April 22, 2019 — A new study finds wide state
Stereotactic Radiosurgery Effective for Pediatric Arteriovenous Malformation Patients
News | Radiation Therapy | April 19, 2019
Ching-Jen Chen, M.D., of the neurosurgery department at the University of Virginia (UVA) Health System, was the winner...
Surgically Guided Brachytherapy Improves Outcomes for Intracranial Neoplasms
News | Brachytherapy Systems | April 18, 2019
Peter Nakaji, M.D., FAANS, general practice neurosurgeon at Barrow Neurological Institute, presented new research on...
ASTRO Applauds Introduction of PIMA Patient Protection Bill
News | Radiology Business | April 15, 2019
The American Society for Radiation Oncology (ASTRO) hailed the introduction of federal legislation that would...
Qaelum NV and Toyo Corp. Sign Japanese Distribution Agreement for Dose Monitoring Solution
News | Radiation Dose Management | April 10, 2019
Qaelum NV of Leuven, Belgium, and Toyo Corp. of Tokyo, Japan announced they have entered into a cooperation agreement...
Varian Discloses First Preclinical Results of Flash Therapy in Cancer Treatment
News | Proton Therapy | April 09, 2019
Varian, in partnership with the University of Maryland School of Medicine’s Department of Radiation Oncology and the...